Summit Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Summit Therapeutics Inc.‘s stocks are currently a part of 53 hedge funds’ portfolios, which represents 2.58% of the total amount of its stocks outstanding. This makes up a total of 4.99M shares of Summit Therapeutics Inc.. Compared to the previous quarter, the number fell by -37.99% or -3.05M shares fewer. As for the holding position changes, 41.51% (22) of current hedge fund investors increased the number of shares held, 11.32% (6) of current holders sold a part of the shares held, and 5.66% (3) closed the holdings completely. 19 hedge funds are new holders of Summit Therapeutics Inc. stock in Q1 2023, it is 35.85% of total holders.
Hedge funds holding Summit Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 15 |
|---|---|
| Q3 2018 | 13 |
| Q4 2018 | 11 |
| Q1 2019 | 13 |
| Q2 2019 | 10 |
| Q3 2019 | 12 |
| Q4 2019 | 12 |
| Q1 2020 | 10 |
| Q2 2020 | 19 |
| Q3 2020 | 19 |
| Q4 2020 | 36 |
| Q1 2021 | 38 |
| Q2 2021 | 57 |
| Q3 2021 | 53 |
| Q4 2021 | 52 |
| Q1 2022 | 48 |
| Q2 2022 | 37 |
| Q3 2022 | 42 |
| Q4 2022 | 60 |
| Q1 2023 | 53 |
Hedge funds changes in Summit Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 2 | 5 | 8 | -4 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 4 | 4 | 4 | -1 |
| Q4 2018 | 3 | 3 | 2 | 5 | -2 |
| Q1 2019 | 5 | 4 | 1 | 3 | 0 |
| Q2 2019 | 0 | 3 | 3 | 3 | 1 |
| Q3 2019 | 3 | 1 | 2 | 1 | 5 |
| Q4 2019 | 4 | 2 | 1 | 4 | 1 |
| Q1 2020 | 3 | 2 | 3 | 4 | -2 |
| Q2 2020 | 11 | 3 | 4 | 3 | -2 |
| Q3 2020 | 17 | 0 | 0 | 17 | -15 |
| Q4 2020 | 23 | 4 | 4 | 5 | 0 |
| Q1 2021 | 8 | 16 | 8 | 6 | 0 |
| Q2 2021 | 27 | 16 | 10 | 8 | -4 |
| Q3 2021 | 4 | 29 | 13 | 8 | -1 |
| Q4 2021 | 8 | 16 | 18 | 9 | 1 |
| Q1 2022 | 8 | 11 | 16 | 11 | 2 |
| Q2 2022 | 11 | 6 | 14 | 22 | -16 |
| Q3 2022 | 12 | 13 | 5 | 7 | 5 |
| Q4 2022 | 27 | 16 | 7 | 9 | 1 |
| Q1 2023 | 19 | 22 | 6 | 3 | 3 |
Hedge funds changes in Summit Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 45,000 |
|---|---|---|
| Q3 2018 | 0 | 51,000 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 1,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 90,000 | 0 |
| Q2 2021 | 1,048,000 | 235,000 |
| Q3 2021 | 638,000 | 129,000 |
| Q4 2021 | 135,000 | 51,000 |
| Q1 2022 | 33,000 | 0 |
| Q2 2022 | 57,000 | 0 |
| Q3 2022 | 94,000 | 0 |
| Q4 2022 | 5,586,625 | 4,634,975 |
| Q1 2023 | 949,765,000 | 405,369,000 |